Benoît Trottier

5.7k total citations · 1 hit paper
68 papers, 2.2k citations indexed

About

Benoît Trottier is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Benoît Trottier has authored 68 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 40 papers in Virology and 21 papers in Emergency Medicine. Recurrent topics in Benoît Trottier's work include HIV Research and Treatment (40 papers), HIV/AIDS drug development and treatment (39 papers) and HIV/AIDS Research and Interventions (30 papers). Benoît Trottier is often cited by papers focused on HIV Research and Treatment (40 papers), HIV/AIDS drug development and treatment (39 papers) and HIV/AIDS Research and Interventions (30 papers). Benoît Trottier collaborates with scholars based in Canada, United States and United Kingdom. Benoît Trottier's co-authors include Sharon Walmsley, Calvin Cohen, Mary O’Hearn, Jain Chung, Jacob Lalezari, Peter J. Piliero, Keith Henry, Ralph DeMasi, Miklos Salgo and Daniel R. Kuritzkes and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Benoît Trottier

64 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America

2003 716 citations Jacob Lalezari, Keith Henry et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Benoît Trottier

Since Specialization

Citations

This map shows the geographic impact of Benoît Trottier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît Trottier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît Trottier more than expected).

Fields of papers citing papers by Benoît Trottier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoît Trottier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît Trottier. The network helps show where Benoît Trottier may publish in the future.

Co-authorship network of co-authors of Benoît Trottier

This figure shows the co-authorship network connecting the top 25 collaborators of Benoît Trottier. A scholar is included among the top collaborators of Benoît Trottier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoît Trottier. Benoît Trottier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort 2025 ·PubMed ·Benoît Trottier, Chia‐Jui Yang, Dai Watanabe, Giulia Marchetti, Daniel Elbirt, Eoghan de Barra, Alper Gündüz, Sun Hee Lee, Roger Vogelmann, Olivier Robineau, Chiaw Yee Choy, Marvin A. H. Berrevoets, Alison Uriel, David Thorpe, (unknown), Andrea Marongiu, (unknown), Lisa D’Amato, Josep Mallolas	1
2	Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV from the Canadian cohort of the observational BICSTaR study 2024 ·Medicine ·Alexander Wong, Jason Brunetta, (unknown), (unknown), Hugues Loemba, (unknown), (unknown), Andrea Marongiu, (unknown), David Thorpe, Benoît Trottier	1
3	Differential Impact of IL-32 Isoforms on the Functions of Coronary Artery Endothelial Cells: A Potential Link with Arterial Stiffness and Atherosclerosis 2023 ·Viruses ·(unknown), Marie‐Hélène Roy Cardinal, (unknown), (unknown), Madéleine Durand, Carl Chartrand‐Lefebvre, Jean‐Pierre Routy, Réjean Thomas, Benoît Trottier, Petronela Ancuța, David B. Hanna, Alan Landay, Guy Cloutier, Cécile Tremblay, Mohamed El‐Far	4
4	The Frequency and Function of NKG2C+CD57+ Adaptive NK Cells in Cytomagalovirus Co-Infected People Living with HIV Decline with Duration of Antiretroviral Therapy 2023 ·Viruses ·(unknown), Franck P. Dupuy, (unknown), Marc Messier-Peet, Madéleine Durand, Cécile Tremblay, Jean‐Pierre Routy, Julie Bruneau, Jean-Guy Baril, Benoît Trottier, Nicole F. Bernard	2
5	Covid-19 vaccine immunogenicity in people living with HIV-1 2022 ·Vaccine ·(unknown), Lorie Marchitto, Guillaume Goyette, (unknown), Claude Fortin, Valérie Martel‐Laferrière, Benoît Trottier, Jonathan Richard, Madéleine Durand, Daniel E. Kaufmann, Andrés Finzi, Cécile Tremblay	45
6	Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIV 2022 ·Frontiers in Cardiovascular Medicine ·Léna Royston, Stéphane Isnard, Nils Perrin, (unknown), Carolina Berini, John Lin, Benoît Trottier, Jean-Guy Baril, Carl Chartrand‐Lefebvre, Cécile Tremblay, Madéleine Durand, Jean‐Pierre Routy	6
7	Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers 2020 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Jean‐Pierre Routy, Cécile Tremblay, Réjean Thomas, Jason Szabo, Pierre Côté, Benoît Trottier, Roger LeBlanc, Danielle Rouleau, Marianne Harris, Franck P. Dupuy, Nicole F. Bernard	7
8	Increased carotid artery wall stiffness and plaque prevalence in HIV infected patients measured with ultrasound elastography 2020 ·European Radiology ·Marie‐Hélène Roy Cardinal, Madéleine Durand, Carl Chartrand‐Lefebvre, Claude Fortin, Jean-Guy Baril, Benoît Trottier, Jean‐Pierre Routy, Gilles Soulez, Cécile Tremblay, Guy Cloutier	16
9	CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection 2019 ·Frontiers in Immunology ·Vikram Mehraj, Rayoun Ramendra, Stéphane Isnard, Franck P. Dupuy, Bertrand Lebouché, Cecilia T. Costiniuk, Réjean Thomas, Jason Szabo, Jean-Guy Baril, Benoît Trottier, Pierre Côté, Roger LeBlanc, Madéleine Durand, Carl Chartrand‐Lefebvre, Ido P. Kema, Yonglong Zhang, Malcolm Finkelman, Cécile Tremblay, Jean‐Pierre Routy	41
10	Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection 2017 ·HIV Clinical Trials ·Chan‐Loi Yong, Joseph Gathe, (unknown), Catherine Orrell, Josep Mallolas, Daniel Podzamczer, Benoît Trottier, (unknown), John P. Sabo, Richard Vinisko, (unknown), (unknown)	3
11	P030: Renal and bone safety of tenofovir alafenamide versus tenofovir disoproxil fumarate 2015 ·Journal of the International AIDS Society ·Edwin DeJesus, (unknown), Michael T. Yin, Frank Post, Shinichi Oka, Ellen Koenig, Benoît Trottier, Jaime Andrade‐Villanueva, Huyen Cao, (unknown), Marshall W. Fordyce	9
12	Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: 96 weeks post VERITAS study 2014 ·Journal of the International AIDS Society ·Benoît Trottier, Danièle Longpré, (unknown), Sylvie Vézina, (unknown), Chrissi Galanakis, Nimâ Machouf, Réjean Thomas	1
13	Antiretroviral therapy for adults infected with HIV: Guidelines for health care professionals from the Quebec HIV care committee 2011 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·Danielle Rouleau, Claude Fortin, Benoît Trottier, Richard Lalonde, Normand Lapointe, Pierre Côté, Jean‐Pierre Routy, (unknown), (unknown), Jean-Guy Baril, (unknown)	4
14	Management and Treatment of Hepatitis B Virus in Patients with Hiv Infection: A Practical Guide for Health Care Professionals 2011 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·Marina B. Klein, Jean-Guy Baril, (unknown), Claude Fortin, Richard Lalonde, (unknown), Marc Poliquin, (unknown), (unknown), Cécile Tremblay, Benoît Trottier, (unknown), Jean‐Pierre Villeneuve	5
15	Impact of the Background Regimen on Virologic Response to Etravirine: Pooled 48-Week Analysis of DUET-1 and -2 2010 ·HIV Clinical Trials ·Benoît Trottier, Giovanni Di Perri, José Valdez Madruga, Monika Peeters, Johan Vingerhoets, Gastón Picchio, Brian Woodfall	9
16	Successful implementation of a national HLA‐B5701 genetic testing service in Canada 2009 ·Tissue Antigens* ·R Lalonde, Réjean Thomas, Anita Rachlis, M. John Gill, Michel Roger, Jonathan B. Angel, Graham Smith, Niamh Higgins, Benoît Trottier	21
17	Randomized Controlled Trial of Once-Daily Tenofovir, Lamivudine, and Lopinavir/Ritonavir Versus Remaining on the Same Regimen in Virologically Suppressed HIV-Infected Patients on Their First PI-Containing HAART Regimen 2007 ·HIV Clinical Trials ·Mona Loutfy, (unknown), Tony Antoniou, Jean-Guy Baril, Brian Conway, (unknown), Benoît Trottier, Colin Kovacs, William A. Thompson, Alain Martel, Sylvie Trottier, Danielle Rouleau, Stephen D. Shafran, Anita Rachlis, Christophe Fraser, Fiona Smaill, Sharon Walmsley, Alice Tseng, John S. Sampalis	3
18	Efficacy of the Protease Inhibitors Tipranavir plus Ritonavir in Treatment-Experienced Patients: 24-Week Analysis from the RESIST-1 Trial 2006 ·Clinical Infectious Diseases ·Joseph Gathe, David A. Cooper, Charles Farthing, Dushyantha Jayaweera, (unknown), Gerald Pierone, (unknown), Benoît Trottier, Sharon Walmsley, Cassy Workman, Geoffrey Mukwaya, Veronika Kohlbrenner, (unknown), Scott McCallister, Douglas L. Mayers, (unknown)	67
19	Factors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in Montreal 2004 ·AIDS ·Jean‐Pierre Routy, Nimâ Machouf, Michael Edwardes, Bluma Brenner, Réjean Thomas, Benoît Trottier, Danielle Rouleau, Cécile Tremblay, Pierre Côté, Jean-Guy Baril, Robert S. Remis, Rafick‐Pierre Sékaly, Mark A. Wainberg	31
20	Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America breakdown → 2003 ·New England Journal of Medicine ·Jacob Lalezari, Keith Henry, Mary O’Hearn, Joan Montaner, Peter J. Piliero, Benoît Trottier, Sharon Walmsley, Calvin Cohen, Daniel R. Kuritzkes, Joseph J. Eron, Jain Chung, Ralph DeMasi, (unknown), (unknown), John Delehanty, Miklos Salgo	716

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact